Translational Development Acquisition (TDACU) Notes Payables (2023 - 2026)

Translational Development Acquisition (TDACU) reported Notes Payables of $500000.0 for Q1 2026, up 150.0% quarter-over-quarter from $200000.0 in Q4 2025.

Translational Development Acquisition (TDACU) Notes Payables (2023 - 2026) Analysis & Trends

Translational Development Acquisition has reported Notes Payables for 3 years, with the latest figure at $500000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Notes Payables changed N/A year-over-year to $500000.0; the trailing twelve-month figure through Mar 2026 stood at $500000.0 (changed N/A YoY), and the FY2025 full-year result was $200000.0, changed N/A from the prior year.
  • Notes Payables for Q1 2026 stood at $500000.0, up from $200000.0 in the prior quarter.
  • The five-year high for Notes Payables was $500000.0 in Q1 2026, with the low at $100000.0 in Q3 2025.
  • Historically, Notes Payables has averaged $286875.0 across 3 years, with a median of $273750.0 in 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 EQV Ventures Acquisition 477.69 Mn 477.69 Mn -
2 Berto Acquisition 312.46 Mn 312.46 Mn -
3 Centurion Acquisition 311.65 Mn 311.65 Mn -
4 GP-Act III Acquisition 311.36 Mn 311.36 Mn -
5 Churchill Capital Corp IX 310.79 Mn 310.79 Mn -
6 WEN Acquisition 309.15 Mn 309.15 Mn -
7 Bold Eagle Acquisition 275.54 Mn 275.54 Mn -
8 Soulpower Acquisition 264.91 Mn 264.91 Mn -
9 BTC Development 262.16 Mn 262.16 Mn -
10 Translational Development Acquisition - - -

Historic Data

Download Data
DateValue
Mar 31, 2026 500,000.00
Dec 31, 2025 200,000.00
Sep 30, 2025 100,000.00
Dec 31, 2023 347,500.00